Effect of BF839+earthworm protein supplement on motor and some non-motor symptoms of Parkinson's disease: a randomized clinical trial

被引:0
作者
Zeng, Ting [1 ]
Lin, Chuhui [1 ]
Deng, Yuhong [1 ,2 ,3 ,4 ,5 ]
Zhu, Weiwen [2 ,3 ,4 ,5 ]
机构
[1] Guangzhou Med Univ, Dept Clin Nutr, Affiliated Hosp 2, Guangzhou, Peoples R China
[2] Guangzhou Med Univ, Inst Neurosci, Affiliated Hosp 2, Guangzhou 510260, Guangdong, Peoples R China
[3] Guangzhou Med Univ, Dept Neurol, Affiliated Hosp 2, Guangzhou, Peoples R China
[4] Key Lab Neurogenet & Channelopathies Guangdong Pro, Guangzhou, Peoples R China
[5] Minist Educ China, Guangzhou, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2024年 / 15卷
关键词
Bacteroides fragilis 839; earthworm; gut microbiota; Parkinson's disease; probiotics; MODEL;
D O I
10.3389/fneur.2024.1371791
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction Some studies have found that probiotics have the potential to treat PD, and earthworm protein is a traditional Chinese medicine used for the treatment of PD. The purpose of this study was to evaluate the safety and efficacy of Bacteroides fragilis 839 (BF839) + earthworm protein supplement as an adjunctive therapy for PD and to observe changes in the gut microbiota. Methods Forty-six patients with PD were recruited for a 12-week 1:1 randomized, double-blind, placebo-controlled clinical trial to evaluate changes in motor and some non-motor symptom scores and detect metagenomic changes in the gut microbiota. Results From baseline to 12 weeks, compared with placebo, the trial group showed significant reductions in the United Parkinson's Disease Rate Scale (UPDRS) total score (-7.74 +/- 5.92 vs. -1.83 +/- 4.14, p < 0.001), UPDRS part I (-0.72 +/- 0.81 vs. -0.20 +/- 0.72, p = 0.026), UPDRS part II (-2.50 +/- 2.24 vs. -0.22 +/- 1.98, p = 0.001), UPDRS part III (-3.43 +/- 3.42 vs. -1.33 +/- 2.65, p = 0.024), and UPDRS part IV (-1.13 +/- 1.19 vs. -0.15 +/- 0.57, p = 0.001). Significant reductions in the Hamilton Depression Scale-24 score (-3.91 +/- 3.99 vs. +1.15 +/- 3.42, p < 0.001), Self-Rating Anxiety Scale scores (-7.04 +/- 5.71 vs. -1.23 +/- 2.34, p < 0.001), and Constipation scoring system scores (-8.59 +/- 4.75 vs. 0.27 +/- 1.24, p < 0.001), were also noted. In the trial group, one patient experienced mild eczema and one suffered low blood pressure, which could not be conclusively attributed to supplementation. Compared to the placebo group, the trial group showed a marked increase in Enterococcus faecium and a decrease in Klebsiella. Conclusion This study is the first to report that probiotics plus earthworm protein can remarkably improve the motor and some non-motor symptoms of PD without serious adverse effects. However, further clinical trials and exploration of the underlying mechanisms are required.
引用
收藏
页数:11
相关论文
共 30 条
[1]  
Borghammer P, 2010, BRAIN STRUCT FUNCT, V214, P303, DOI 10.1007/s00429-010-0246-0
[2]   Next generation probiotics in disease amelioration [J].
Chang, Chih-Jung ;
Lin, Tzu-Lung ;
Tsai, Yu-Ling ;
Wu, Tsung-Ru ;
Lai, Wei-Fan ;
Lu, Chia-Chen ;
Lai, Hsin-Chih .
JOURNAL OF FOOD AND DRUG ANALYSIS, 2019, 27 (03) :615-622
[3]   THE MICROBIOTA-GUT-BRAIN AXIS [J].
Cryan, John F. ;
O'Riordan, Kenneth J. ;
Cowan, Caitlin S. M. ;
Sandhu, Kiran V. ;
Bastiaanssen, Thomaz F. S. ;
Boehme, Marcus ;
Codagnone, Martin G. ;
Cussotto, Sofia ;
Fulling, Christine ;
Golubeva, Anna V. ;
Guzzetta, Katherine E. ;
Jaggar, Minal ;
Long-Smith, Caitriona M. ;
Lyte, Joshua M. ;
Martin, Jason A. ;
Molinero-Perez, Alicia ;
Moloney, Gerard ;
Morelli, Emanuela ;
Morillas, Enrique ;
O'Connor, Rory ;
Cruz-Pereira, Joana S. ;
Peterson, Veronica L. ;
Rea, Kieran ;
Ritz, Nathaniel L. ;
Sherwin, Eoin ;
Spichak, Simon ;
Teichman, Emily M. ;
van de Wouw, Marcel ;
Ventura-Silva, Ana Paula ;
Wallace-Fitzsimons, Shauna E. ;
Hyland, Niall ;
Clarke, Gerard ;
Dinan, Timothy G. .
PHYSIOLOGICAL REVIEWS, 2019, 99 (04) :1877-2013
[4]   Finding a needle in a haystack: Bacteroides fragilis polysaccharide A as the archetypical symbiosis factor [J].
Erturk-Hasdemir, Deniz ;
Kasper, Dennis L. .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2018, 1417 (01) :116-129
[5]   Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease [J].
Hasegawa, Satoru ;
Goto, Sae ;
Tsuji, Hirokazu ;
Okuno, Tatsuya ;
Asahara, Takashi ;
Nomoto, Koji ;
Shibata, Akihide ;
Fujisawa, Yoshiro ;
Minato, Tomomi ;
Okamoto, Akira ;
Ohno, Kinji ;
Hirayama, Masaaki .
PLOS ONE, 2015, 10 (11)
[6]   PARKINSONISM - ONSET PROGRESSION AND MORTALITY [J].
HOEHN, MM ;
YAHR, MD .
NEUROLOGY, 1967, 17 (05) :427-&
[7]   Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders [J].
Hsiao, Elaine Y. ;
McBride, Sara W. ;
Hsien, Sophia ;
Sharon, Gil ;
Hyde, Embriette R. ;
McCue, Tyler ;
Codelli, Julian A. ;
Chow, Janet ;
Reisman, Sarah E. ;
Petrosino, Joseph F. ;
Patterson, Paul H. ;
Mazmanian, Sarkis K. .
CELL, 2013, 155 (07) :1451-1463
[8]   Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson's Disease [J].
Hsieh, Tsung-Hsun ;
Kuo, Chi-Wei ;
Hsieh, Kai-Hsuan ;
Shieh, Meng-Jyh ;
Peng, Chih-Wei ;
Chen, Yen-Chien ;
Chang, Ying-Ling ;
Huang, Ying-Zu ;
Chen, Chih-Chung ;
Chang, Pi-Kai ;
Chen, Kai-Yun ;
Chen, Hsin-Yung .
BRAIN SCIENCES, 2020, 10 (04)
[9]   Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson's disease: A randomised controlled trial [J].
Ibrahim, Azliza ;
Ali, Raja Affendi Raja ;
Manaf, Mohd Rizal Abdul ;
Ahmad, Norfazilah ;
Tajurruddin, Farah Waheeda ;
Qin, Wong Zhi ;
Desa, Siti Hajar Md ;
Ibrahim, Norlinah Mohamed .
PLOS ONE, 2020, 15 (12)
[10]  
Jin LR, 2000, CLIN HEMORHEOL MICRO, V23, P213